Vitreous band formation and the sustained-release, intravitreal fluocinolone (Retisert) implant.
نویسندگان
چکیده
corneas. Invest Ophthalmol Vis Sci. 2000;41: 2514-2522. 3. Maguire MG, Stark WJ, Gottsch JD, et al. Risk factors for corneal graft failure and rejection in the collaborative corneal transplantation studies: Collaborative Corneal Transplantation Studies Research Group. Ophthalmology. 1994;101: 1536-1547. 4. Rosenfeld PJ,MoshfeghiAA,PuliafitoCA.Optical coherence tomography findings after an intravitreal injectionofbevacizumab(Avastin) forneovascular age-related macular degeneration. Ophthalmic Surg Lasers Imaging. 2005;36:331-335. 5. Amano S, Rohan R, Kuroki M, Tolentino M, Adamis AP. Requirement for vascular endothelial growth factor in woundand inflammationrelated corneal neovascularization. Invest Ophthalmol Vis Sci. 1998;39:18-22. 6. Ren M, Manzano RPA, Peyman GA, Khan P, Carvounis P, Kivilcim M. Inhibition of experimental angiogenesis of cornea by bevacizumab [poster 1638/B365]. Presented at: Association for Research in Vision and Ophthalmology Annual Meeting; May 1, 2006; Fort Lauderdale, Fla.
منابع مشابه
Comment on: “Use of the Fluocinolone Acetonide Intravitreal Implant for the Treatment of Noninfectious Posterior Uveitis: 3-Year Results of a Randomized Clinical Trial in a Predominantly Asian Population”
I read ''Use of the fluocinolone acetonide intravitreal implant for the treatment of noninfectious posterior uveitis (NIPU): 3-year results of a randomized clinical trial in a predominantly Asian population'' (December 2014) [1]. This article is certainly of interest, especially regarding the effectiveness of 0.59 and 2.1 mg doses of fluocinolone acetonide (FAc) intravitreal implant for the tre...
متن کاملFluocinolone acetonide intravitreal sustained release device – a new addition to the armamentarium of uveitic management
Uveitis is a potentially sight-threatening inflammatory eye disease caused by multiple infectious and non-infectious etiologies for which the standard of care involves corticosteroids or various immunomodulary therapy (IMT) drugs. These available treatments, although effective, may cause significant morbidity and sometimes mortality in uveitis patients due to their toxic side-effects and the ne...
متن کاملEfficacy of low-release-rate fluocinolone acetonide intravitreal implants to treat experimental uveitis.
OBJECTIVE To determine the efficacy of 0.5-mg and 0.1-mg sustained-release fluocinolone acetonide intravitreal implants to inhibit ocular inflammation in a rabbit model of severe uveitis. METHODS The in vitro pharmacokinetic profile of both the 0.5-mg and 0.1-mg sustained-release fluocinolone intravitreal implants was determined during a 10-day period. A sustained-release fluocinolone acetoni...
متن کاملScleral melt following Retisert intravitreal fluocinolone implant
Intravitreal fluocinolone acetonide implant (Retisert) has a high potency, a low solubility, and a very short duration of action in the systemic circulation, enabling the steroid pellet to be small and reducing the risk of systemic side effects. Scleral melt has not been reported as a possible complication of Retisert implant. The authors describe the occurrence of scleral melt 18 months after ...
متن کاملReply to Hall J: “Use of the Fluocinolone Acetonide Intravitreal Implant for the Treatment of Noninfectious Posterior Uveitis: 3-Year Results of a Randomized Clinical Trial in a Predominantly Asian Population”
I read with interest Dr. Hall’s letter. While the article titled ‘‘Use of the Fluocinolone Acetonide Intravitreal Implant for the Treatment of Noninfectious Posterior Uveitis (NIPU): 3-Year Results of a Randomized Clinical Trial in a Predominantly Asian Population’’ [1] clearly identified Retisert (fluocinolone acetonide intravitreal implant) 0.59 mg as the marketed product used in the study, w...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Archives of ophthalmology
دوره 125 6 شماره
صفحات -
تاریخ انتشار 2007